146 related articles for article (PubMed ID: 14609294)
1. Investigation of the physical stability of amorphous drug and drug/polymer melts using variable temperature solid state NMR.
Forster A; Apperley D; Hempenstall J; Lancaster R; Rades T
Pharmazie; 2003 Oct; 58(10):761-2. PubMed ID: 14609294
[No Abstract] [Full Text] [Related]
2. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
Huang J; Wigent RJ; Schwartz JB
J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR.
Apperley DC; Forster AH; Fournier R; Harris RK; Hodgkinson P; Lancaster RW; Rades T
Magn Reson Chem; 2005 Nov; 43(11):881-92. PubMed ID: 16059964
[TBL] [Abstract][Full Text] [Related]
4. Comparison of high sensitivity micro differential scanning calorimetry with X-ray powder diffractometry and FTIR spectroscopy for the characterization of pharmaceutically relevant non-crystalline materials.
Song M; Liebenberg W; De Villiers MM
Pharmazie; 2006 Apr; 61(4):336-40. PubMed ID: 16649550
[TBL] [Abstract][Full Text] [Related]
5. Solid-state nuclear magnetic resonance study of the physical stability of electrospun drug and polymer solid solutions.
Brettmann BK; Myerson AS; Trout BL
J Pharm Sci; 2012 Jun; 101(6):2185-93. PubMed ID: 22411707
[TBL] [Abstract][Full Text] [Related]
6. Preparation of Amorphous Composite Particles of Drugs with Ursodeoxycholic Acid as Preclinical Formulations.
Tanida S; Yoshimoto A; Yoshida M; Uchiyama H; Kadota K; Tozuka Y
Chem Pharm Bull (Tokyo); 2019; 67(9):921-928. PubMed ID: 31474730
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system.
Yamamura S; Gotoh H; Sakamoto Y; Momose Y
Eur J Pharm Biopharm; 2000 May; 49(3):259-65. PubMed ID: 10799818
[TBL] [Abstract][Full Text] [Related]
8. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.
Wang X; de Armas HN; Blaton N; Michoel A; Van den Mooter G
Int J Pharm; 2007 Dec; 345(1-2):95-100. PubMed ID: 17604923
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems.
Meng F; Dave V; Chauhan H
Eur J Pharm Sci; 2015 Sep; 77():106-11. PubMed ID: 26006307
[TBL] [Abstract][Full Text] [Related]
10. Investigation of Phase Mixing in Amorphous Solid Dispersions of AMG 517 in HPMC-AS Using DSC, Solid-State NMR, and Solution Calorimetry.
Calahan JL; Azali SC; Munson EJ; Nagapudi K
Mol Pharm; 2015 Nov; 12(11):4115-23. PubMed ID: 26457879
[TBL] [Abstract][Full Text] [Related]
11. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc.
Sun Y; Tao J; Zhang GG; Yu L
J Pharm Sci; 2010 Sep; 99(9):4023-31. PubMed ID: 20607809
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine.
Caira MR; Robbertse Y; Bergh JJ; Song M; De Villiers MM
J Pharm Sci; 2003 Dec; 92(12):2519-33. PubMed ID: 14603498
[TBL] [Abstract][Full Text] [Related]
13. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of amorphous indomethacin by co-grinding in a ternary mixture.
Watanabe T; Ohno I; Wakiyama N; Kusai A; Senna M
Int J Pharm; 2002 Jul; 241(1):103-11. PubMed ID: 12086726
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Gordon-Taylor and Couchman-Karasz equations for prediction of the glass transition temperature of glass solutions of drug and polyvinylpyrrolidone prepared by melt extrusion.
Forster A; Hempenstall J; Rades T
Pharmazie; 2003 Nov; 58(11):838-9. PubMed ID: 14664344
[No Abstract] [Full Text] [Related]
17. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
Karmwar P; Boetker JP; Graeser KA; Strachan CJ; Rantanen J; Rades T
Eur J Pharm Sci; 2011 Oct; 44(3):341-50. PubMed ID: 21884789
[TBL] [Abstract][Full Text] [Related]
18. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
19. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
20. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
Duong TV; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
